{
    "nct_id": "NCT01265394",
    "title": "A Single-arm, Open-label, Multi-center Study to Determine the Specificity of Flutemetamol (18F) Injection for Excluding the Presence of Brain Amyloid in Healthy Young Adult Subjects Aged 18 to 40",
    "status": "COMPLETED",
    "last_update_time": "2013-06-21",
    "description_brief": "Amyloid is an abnormal chemical found in the brain of patients with Alzheimer's Disease (AD). The study drug helps produce pictures of amyloid in the brain. The purpose of this study is to determine how well the study drug performs in young healthy subjects.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "DIAGNOSTIC",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "(18F) Flutemetamol",
                    "description": "\\[18F\\] Flutemetamol : Flutemetamol (18F) Injection, 185 MBq/5 mCi, single intravenous injection."
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "218"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "181"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "37"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Subjects withdrawn",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "37"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "This is the number of participants that completed.",
            "groups": [
                {
                    "id": "BG000",
                    "title": "(18F) Flutemetamol",
                    "description": "\\[18F\\] Flutemetamol : Flutemetamol (18F) Injection, 185 MBq/5 mCi, single intravenous injection."
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "181"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "181"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "29",
                                            "spread": "5.9"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "103"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "78"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "127"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Belgium",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Finland",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "United Kingdom",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "25"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Number of Brain Scans in Healthy Young Adults Subjects Which do Not Show Amyloid",
                    "description": "The visual assessment of Flutemetamol PET image was performed by independent readers trained in the evaluation of PET brain amyloid imaging.\n\nThe measure would consisted of the number of brain scans with amyloid (abnormal reading) or without amyloid (normal reading).",
                    "populationDescription": "Healthy young adult subjects aged 18 to 40 are presumed to be amyloid negative",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "Brain Scans Read",
                    "timeFrame": "PET scans performed on patients 90 minutes post Flutemetmol Administration",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Normal and Abnormal Reads With or Without Amyloid",
                            "description": "Each Subject received a dose of \\[18F\\] Flutemetamol : Flutemetamol (18F) Injection, 185 MBq/5 mCi, single intravenous injection."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "181"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Reader 1 -Normal Read-no amyloid",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "181",
                                            "lowerLimit": "98.0",
                                            "upperLimit": "100.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 1- Abnormal Read- amyloid is present",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0",
                                            "lowerLimit": "60.6",
                                            "upperLimit": "74.7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 2 - Normal Read-no amyloid",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "123",
                                            "lowerLimit": "97.0",
                                            "upperLimit": "100.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 2 - Abnormal Read-amyloid is present",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "58",
                                            "lowerLimit": "97.0",
                                            "upperLimit": "100.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 3 - Normal Read-no amyloid",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "180",
                                            "lowerLimit": "96.1",
                                            "upperLimit": "99.9"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 3 - Abnormal Read-amyloid is present",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 4 - Normal Read-no amyloid",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "180"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 4 - Abnormal Read-amyloid is present",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 5 - Normal Read-no amyloid",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "179"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Reader 5 - Abnormal Read-amyloid is present",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Measurement of Amyloid Content in Different Parts of the Brain",
                    "description": "Is the computerized measurement of amyloid content in different parts of the brain.\n\nThe Standard Uptake Value Ratio (SUVR) is defined as an average of frontal, anterior cingulate, pariteal, lateral-temporal and posterior cingulate / precuneous uptake following administration of Flutemetamol F18 Injection.\n\nThe Standard Uptake Value Ratio is calculated for two regions of the brain, the Cerebullum and the Pons regions.\n\nThe Standard Uptake Value Ratio is calculated for two regions of the brain, the Cerebullum and the Pons regions. Both regions of the brain will provide the SUVR measurements.",
                    "populationDescription": "The Standard Uptake Value Ratio is calculated for two regions of the brain, the Cerebullum and the Pons regions. Both regions of the brain will provide the SUVR measurements.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Standard Uptake Value Ratio ( SUVR)",
                    "timeFrame": "PET scans performed on patients 90 minutes post Flutemetmol Administration",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "(18F) Flutemetamol Injection",
                            "description": "Flutemetamol (18F) Injection, 185 MBq/5 mCi, single intravenous injection."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "181"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Cerebullum Region",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.12",
                                            "spread": "0.097",
                                            "lowerLimit": "1.108",
                                            "upperLimit": "1.136"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Pons Region",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.49",
                                            "spread": "0.036",
                                            "lowerLimit": "0.487",
                                            "upperLimit": "0.498"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "(18F) Flutemetamol",
                    "description": "\\[18F\\] Flutemetamol : Flutemetamol (18F) Injection, 185 MBq/5 mCi, single intravenous injection.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 181,
                    "otherNumAffected": 27,
                    "otherNumAtRisk": 181
                }
            ],
            "otherEvents": [
                {
                    "term": "Gastrointestinal disorders",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 13.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 9,
                            "numAffected": 9,
                            "numAtRisk": 181
                        }
                    ]
                },
                {
                    "term": "General Disorders and Administration Site Conditions",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 13.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 12,
                            "numAffected": 12,
                            "numAtRisk": 181
                        }
                    ]
                },
                {
                    "term": "Vascular System Disorders",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 13.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 11,
                            "numAffected": 11,
                            "numAtRisk": 181
                        }
                    ]
                },
                {
                    "term": "Vascular System Disorders-Flushing",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 13.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 10,
                            "numAffected": 10,
                            "numAtRisk": 181
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Dr. Paul Sherwin",
                "organization": "GE Healthcare",
                "email": "paulsherwin@ge.com",
                "phone": "1-609-514-6820"
            }
        }
    },
    "target_category": "N/A",
    "drug": [
        "Flutemetamol (18F) (Vizamyl) \u2014 an 18F-labeled PET radiotracer that binds brain \u03b2-amyloid"
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The description and title state the agent 'helps produce pictures of amyloid in the brain' and the study is to determine how well it performs in healthy young subjects \u2014 i.e., a diagnostic PET imaging tracer rather than a therapeutic. Flutemetamol (18F) is a radiopharmaceutical that binds \u03b2-amyloid deposits for PET imaging. \ue200cite\ue202turn0search7\ue202turn0search0\ue201",
        "Act: Key extracted details \u2014 drug name: Flutemetamol (18F), brand Vizamyl; drug type: 18F-labeled amyloid PET tracer (radiopharmaceutical); trial purpose: assess specificity/excluding presence of brain amyloid in healthy 18\u201340 year olds (diagnostic performance). Sources describing the tracer and the trial are provided. \ue200cite\ue202turn0search5\ue202turn0search4\ue202turn0search7\ue201",
        "Reflect: This is not a disease-modifying biologic or small molecule therapeutic, nor a cognitive-enhancer or neuropsychiatric symptom treatment. It is a diagnostic imaging agent used to detect amyloid pathology; therefore it does not fit the four therapeutic categories and is classified as 'N/A'. Supporting references: tracer mechanism and diagnostic use (binds amyloid, PET radiotracer) and relevant clinical trial references. \ue200cite\ue202turn0search0\ue202turn0search3\ue202turn0search7\ue201"
    ],
    "agent_type": "N/A",
    "explanation_agent": []
}